Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The term 'REBUILD' is non-specific and refers to several distinct products and concepts across different domains. It is used as the name for an investigational medical device designed to support abdominal wall closure after laparotomy by distributing suture tension. 'Herbalife 24 Rebuild Strength' is a protein-amino acid dietary supplement aimed at reducing exercise-induced muscle damage, accelerating recovery, supporting immune function, and promoting muscle repair. 'REBUILD-SM' is a purpose-built smartphone app and self-management package for individuals with interstitial lung disease, focusing on improving health-related quality of life, symptoms, anxiety, self-efficacy, and physical activity. Additionally, 'REBUILD' is used as a study name for a clinical trial investigating pulsed inhaled nitric oxide for pulmonary fibrosis, and conceptually in various contexts such as rebuilding trust, intestinal flora, or core life skills.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on REBUILD.